Pipeline Review of Aspergillosis Market and Therapeutics Development for H2 2015

Feb 29, 2016, 05:00 ET from ReportsnReports

PUNE, India, February 29, 2016 /PRNewswire/ --

Market research report titled "Aspergillosis - Pipeline Review, H2 2015" provides an overview of the Aspergillosis's therapeutic pipeline and helps enhance decision making capabilities to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Company Profiles discussed in this report includes Amplyx Pharmaceuticals, Inc., Astellas Pharma Inc., Aureogen Biosciences, Inc., Biomar Microbial Technologies, Cidara Therapeutics, Inc., Eisai Co., Ltd., F2G Ltd, Globavir Biosciences, Inc., Hsiri Therapeutics, LLC, iCo Therapeutics Inc., Merck & Co., Inc., Nanomerics Ltd, Novabiotics Limited, Pulmocide Ltd, Scynexis, Inc., Sealife PHARMA GMBH, Sigma-Tau S.p.A., TGV-Laboratories and Vical Incorporated. Drugs Profiles discussed in this report includes amphotericin b, amphotericin B, amphotericin b NanoDisk, APX-001, ASP-9726, Aspergillus fumigatus vaccine, AUGC-10, AUGC-15, C-001, C-016, E-1210, F-901318, GBV-006, KB-425796C, MDN-0018, Myc-102, NP-339, NP-525, posaconazole, PTX-3, SCY-078, SLP-0901, SLP-0904, Small Molecule for Aspergillosis, Small Molecules for Aspergillosis and Candidiasis, Small Molecules for Fungal Infections, Small Molecules for Invasive Pulmonary Aspergillosis, Small Molecules to Inhibit ABC Transporter for Fungal  and Infections and VL-2397. Complete report on H2 2015 pipeline review of Aspergillosis with 37 market data tables and 15 figures, spread across 98 pages is available at http://www.reportsnreports.com/reports/459923-aspergillosis-pipeline-review-h2-2015.html .

This report provides comprehensive information on the therapeutic development for Aspergillosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Aspergillosis and special features on late-stage and discontinued projects.

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Aspergillosis. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and also key players involved in the therapeutics development for Aspergillosis and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects.

Order a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=459923 .

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Aspergillosis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Aspergillosis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Another market research report titled Enterococcus faecium Infections - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Enterococcus faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Enterococcus faecium Infections and special features on late-stage and discontinued projects. Enterococcus faecium Infections market research report is available at http://www.reportsnreports.com/reports/459908-enterococcus-faecium-infections-pipeline-review-h2-2015.html .

Explore more reports on pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect With Us on:  

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds:   http://www.reportsnreports.com/feed/l-latestreports.xml


SOURCE ReportsnReports